Matinas BioPharma Balance Sheet
Matinas BioPharma's total assets for Q4 2025 were $7.21M, a decrease of -25.65% from the previous quarter. MTNB total liabilities were $2.38M for the fiscal quarter, a -26.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.